Actalent provides integrated clinical services that span the entire product development lifecycle. We can support specific functional areas of a clinical trial and oversee trial management responsibilities. Our expertise and offerings include clinical trial management, quality and compliance, regulatory affairs, medical affairs, biometrics, and data management. Our services are customizable, scalable, and aligned with our client’s project, program, and operational requirements. Our solutions can be delivered on-premises, off-site, fully remote, or as a hybrid combination of all three. For more information, please visit Actalentservices.com

ExtruPharm, established in 2018, is a Contract Design and Manufacturing Organization specializing in the development of Hot Melt Extrusion processes. Areas of focus include developing custom drug eluting implants and parenteral devices for direct to target and systemic release while unitizing various twin-screw extrusion, single screw-extrusion and injection molding operations as its core competency. Common and custom device shapes include but are not limited to; films, rods, tubes, co-extruded products, and custom geometries. Challenging processes are our specialty. ExtruPharm also offers the following services of; cryogenic milling of polymers, small scale prototyping, die cutting, injection molding, high potency compounds, GMP equipment design, GMP equipment specification, equipment procurement, onsite training, onsite product development and consulting. ExtruPharm has recently opened a 5,500sf R&D facility located in Auburn MA capable of producing analytical and animal study prototypes with paths to GMP manufacturing. Our more than competitive rates will ensure your company is able to produce the samples you need without over extending your budget. ExtruPharm is also open to partnering with your startup or specific project for device manufacturing, device design, and technical support.

DelSiTech is a technology platform company specializing in long-acting formulations, dedicated to transforming the treatment landscape in the areas of metabolic disease and pain through our lead long-acting injectable assets. DelSiTech’s proprietary Silica Matrix technology platform is highly versatile and has demonstrated compatibility with a wide range of therapeutic agents, including small molecules, peptides, and large biologics. The product can be formulated to release drug over days, weeks, or even months, providing patients and caregivers with possible access to long-lasting treatment options.

Phases is building Polly, your AI patient recruiter. Polly gives sponsors complete, real-time visibility into recruitment. She centralizes and automates prescreening, engagement, education, and visit scheduling across sites, central advertising campaigns, and databases. Operating 24/7 in 31+ languages over voice, chat, text, and email, Polly instantly prescreens to identify eligible patients, books them into the nearest site, and even arranges transport. This gives sponsors real-time enrollment tracking, site-level performance insights, and the ability to adjust strategy on the fly, delivering faster Last Patient In and drastically reducing the risk of costly delays from fragmented, low-visibility recruitment. For more information, please visit https://www.phases.ai/

ProMed Pharma is a U.S.-based CDMO specializing in long-acting injectable and implantable dosage forms, using technologies such as molding, extrusion, and microencapsulation of polymers such as silicones, thermoplastics, and biodegradables. With nearly two decades of experience, we support our partners through formulation, tech‑transfer, clinical manufacturing, and commercial production. Whether you represent an emerging biotech venture or a global pharmaceutical entity, entrust as we translate your scientific concepts into finished dosage forms.

BBS Automation is a global leader in custom automation, delivering high-precision, scalable solutions across life sciences, mobility, energy, and consumer sectors. We partner early to optimize designs, then build fully integrated, validated production lines that reduce risk and maximize throughput—leveraging robotics, vision, testing, and Industry 4.0 technologies.

BRCR Global drives innovation in clinical research through a strategic network of sites across the U.S. and Latin America. Guided by ethics, quality, and a genuine commitment to human life, we advance hope and meaningful progress where it matters most. To learn more, please visit: https://brcrglobal.com/about-us/

Ripple Therapeutics is clinical stage biotech company with a focus on treating ophthalmic diseases. The company's core technology is based on a discovery that drugs can be chemically engineered into controlled release pharmaceuticals without an added delivery system. These prodrugs are highly customized to tailor both the drug dose and duration, resulting in an improved safety profile, extended therapeutic benefit and reduced treatment burden for both the patient and their physician. While we are focused on ophthalmology the platform has broad applications for indications where sustained drug delivery is needed.

Kimball Solutions is a single-source partner specializing in medical contract manufacturing. They offer end-to-end solutions across the entire product lifecycle—from design and prototyping to manufacturing, testing, and aftermarket support. Kimball Solutions' core capabilities include the manufacturing of drug delivery devices (auto injectors), single-use medical devices, and comprehensive medical device and product assembly. Kimball Solutions combines technical expertise, disciplined processes, and a relationship-driven culture to deliver reliable, customized solutions for the medical and life sciences industries. Kimball Medical Solutions combines technical expertise, disciplined processes, and a relationship-driven culture to deliver reliable, customized solutions for the medical and life sciences industries.

Vaxxas is creating a healthier world through patient-focused innovation, providing a needle-free, cost-effective vaccination technology for self-administration.

REDCap Cloud helps life sciences modernize clinical development by integrating real-world evidence and clinical trial data to deliver precision medicine at scale. Its next-gen unified data management platform and purpose-built Statistical Computing Environment (SCE) empowers organizations to accelerate discoveries, connect research with care, and redefine innovation standards. For more information, please visit www.redcapcloud.com   

Veranex is the world's first global Innovation Contract Research Organization (iCRO). Founded in 2021 but with a legacy over 20 years, Veranex combines design engineering, preclinical research, clinical trials, regulatory affairs, quality consulting, manufacturing, and market access services under one roof across various medtech markets. This integrated approach eliminates traditional handoffs between development phases, reducing timelines and budget variance for clients. For more information please visit https://veranex.com/